Modelling cortical cataractogenesis. 15: Use of combined dietary anti-oxidants to reduce cataract risk.
Trevithick
J R
JR
Department of Biochemistry, University of Western Ontario, London, Canada.
Linklater
H A
HA
Dzialoszynski
T
T
McLeod
H
H
Sanford
S E
SE
Robertson
J M
JM
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D001082:Aqueous Humor / Q000378:metabolism; D002386:Cataract / Q000378:metabolism / Q000517:prevention & control*; D003459:Crystallins / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000150:complications* / Q000378:metabolism; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D005260:Female; D051381:Rats; D017208:Rats, Wistar; D012307:Risk Factors; D014822:Vitreous Body / Q000378:metabolism
D000975:Antioxidants; D003459:Crystallins; D000255:Adenosine Triphosphate